Results 141 to 150 of about 9,512,297 (363)

Generalized Lymphatic Anomaly and Gorham–Stout Disease: Overview and Recent Insights

Advances in wound care, 2019
Significance: Generalized lymphatic anomaly and Gorham–Stout disease are extremely rare diseases with severe symptoms and poor prognosis. The etiology and clinical presentation of the patients remain poorly defined, but recent research has attempted to ...
M. Ozeki, T. Fukao
semanticscholar   +1 more source

Optimization of the Nonclinical Biological Evaluation of Medical Devices Using Toxicologic Pathology Best Practices

Advanced Healthcare Materials, EarlyView.
Nonclinical evaluation of biological responses to implanted medical devices and combination products in animals is required to predict possible outcomes and risks in patients. This paper describes globally accepted pathology “best practices” that 1) effectively address ISO standards and current regulatory guidance for medical device development and 2 ...
Kathleen A. Funk, JoAnn C. L. Schuh, Brad Bolon, Valerie S. Thomas, Jeffrey I. Everitt, Abraham Nyska, Jaime Paulin   +6 more
wiley   +1 more source

MLC stimulatory capacity and production of blastogenic factor in patients with chronic lymphatic leukemia and Hodgkin's disease [PDF]

, 1975
S Kasakura
openalex   +3 more sources

In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease [PDF]

, 2020
Mi‐Kyung Han, Julia Watts, Azemat Jamshidi‐Parsian, Urooba Nadeem, Mustafa Sarimollaoglu, Eric R. Siegel, Vladimir P. Zharov, Ekaterina I. Galanzha   +7 more
openalex   +1 more source

The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies

Orphanet Journal of Rare Diseases, 2019
BackgroundLymphatic anomalies (LAs) include several disorders in which abnormal lymphatic tissue invades the neck, chest, and various organs. Progressive cases may result in lethal outcomes and have proven difficult to treat.
M. Ozeki, Akifumi Nozawa, Shiho Yasue, S. Endo, Ryuta Asada, H. Hashimoto, T. Fukao   +6 more
semanticscholar   +1 more source

Bioprinting Organs—Science or Fiction?—A Review From Students to Students

Advanced Healthcare Materials, EarlyView.
Bioprinting artificial organs has the potential to revolutionize the medical field. This is a comprehensive review of the bioprinting workflow delving into the latest advancements in bioinks, materials and bioprinting techniques, exploring the critical stages of tissue maturation and functionality.
Nicoletta Murenu, Camilla Mussoni, Mateo S. Andrade Mier, Paula Buettner, Nathaly Chicaiza‐Cabezas, Yi‐Yu Robin Dai, Jessica Faber, Maren Fiedler, Zan Lamberger, Xuen Jen Ng, Vanessa Moessler, Anna Rederer, Jonas Roeder, Sabrina Stecher, Katinka Theis, Jeanette Weigelt, Silvia Budday, Gregor Lang, Natascha Schaefer   +18 more
wiley   +1 more source

New targets of nascent lymphatic vessels in ocular diseases

Frontiers in Physiology
Recent advancements in the field of endothelial markers of lymphatic vessels and lymphangiogenic factors have shed light on the association between several ocular diseases and ocular nascent lymphatic vessels.
Xuhui Wu, Yunkun Ma, Zhaochen Zhang, Tingting Hou, Yuxi He   +4 more
doaj   +1 more source

Shedding Light on the Cellular Uptake Mechanisms of Bioactive Glass Nanoparticles as Controlled Intracellular Delivery Platforms: A Review of the Recent Literature

Advanced Healthcare Materials, EarlyView.
This review summarizes the main uptake pathways of bioactive glass nanoparticles (BGNs) and their intracellular localization, highlighting that BGNs are mainly internalized and entrapped within endosomes/lysosomes. Strategies for controlled intracellular ion release, with implications for targeted modulation of cell behavior, are discussed. The need to
Andrada‐Ioana Damian‐Buda, Aldo R. Boccaccini   +1 more
wiley   +1 more source

Endovenous bypass is an option in symptomatic patients with unsalvageable iliac vein stents

Journal of Vascular Surgery Cases and Innovative Techniques
Stent occlusion after stenting for chronic iliofemoral venous disease has an incidence of around 3% to 12% in the literature. The reasons for such occlusion vary, with patient and stent-related factors playing a role.
Arjun Jayaraj, MD, FACS
doaj   +1 more source

In Wuchereria bancrofti filariasis, asymptomatic microfilaraemia does not progress to amicrofilaraemic lymphatic disease [PDF]

, 2001
Senarath Dissanayake
openalex   +1 more source